Search

everythinglearnresearchcommunity

for

Search:↓

Higher fluence in hair removal damages hair follicles more, while lower fluence mimics natural hair regression, with long-term IPL treatments effectively reducing hair.

Azathioprine can cause severe blood issues and hair loss, needing careful monitoring and possible discontinuation.

The research found that Atypical Progeroid Syndrome has unique symptoms and is not caused by the buildup of a certain mutant protein.

Older skin has higher cancer risk due to inflammation and stem cell issues.

Researchers created a mouse model for Cushing's syndrome to study glucocorticoid excess and potential treatments.

The article concludes that hair loss is a common side effect of drugs treating skin cancer by blocking the hedgehog pathway, but treatment should continue, and more selective drugs might prevent this side effect.

Removing a methyl group from the ITGAV gene speeds up bone formation in a specific type of bone disease model.

Lipopolysaccharides boost wheat seedling growth, but procyanidin B2 weakens this effect.

Wnt and Shh signaling are key in noggin-induced tumors, and blocking them can slow tumor growth.

Blocking both main energy pathways can stop hair follicle stem cell-induced skin cancer growth.

Budesonide and N-acetylcysteine reduced tumors and alopecia in mice, regardless of FHIT gene status.

AHCC reduces hair loss and liver injury caused by chemotherapy in rodents.

A specific RNA modification in cashmere goats helps activate hair growth-related stem cells.

The document concludes that assessing hair follicle damage due to cyclophosphamide in mice involves analyzing structural changes and suggests a scoring system for standardized evaluation.

Radiation mainly affects keratinocyte stem cells, not melanocyte stem cells, causing hair to gray.

PKC ε increases hair follicle stem cell turnover and may raise skin cancer risk.

Excessive eyelash growth from erlotinib may indicate positive tumor response and help treat madarosis.

A protein called CBP is found in prostate cancer and can increase the effectiveness of certain prostate cancer treatments.

Triptolide effectively and safely reduces actinic keratosis lesions in mice.

Decreasing MIG6 can increase the movement and invasiveness of MEK-inhibited mutant NRAS melanoma, particularly when stimulated by EGF.

Skin organoids with NCSTN mutation show changes in hair follicle development and higher inflammation, key features of Hidradenitis Suppurativa.

Mutations in specific keratin genes cause improper hair structure in mice due to faulty keratin protein assembly.

The vitamin D receptor is crucial for bone health and affects various body systems, with mutations potentially leading to disease.

Damaging mutations in NFKB2 cause a severe and distinct form of primary immunodeficiency with early-onset and often ACTH-deficiency.

Different STUB1 gene mutations cause varied symptoms in autosomal recessive ataxias.

Different harmful mutations in the CDH3 gene cause HJMD, but symptoms vary among individuals.

Mutations in the androgen receptor gene cause Androgen Insensitivity Syndrome, affecting sexual development.

FOXN1 mutations cause severe immunodeficiency, hair loss, nail issues, and thymus defects.

Chemotherapy toxicity might be reduced by using DNA neutralizing agents.

New techniques have enhanced our understanding of how stem cells function and the role of mutations in aging tissues, which may influence future cancer therapies.